Literature DB >> 7852483

Clinical review 66: Thyroxine suppression therapy for benign nodular disease.

D S Cooper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7852483     DOI： 10.1210/jcem.80.2.7852483

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Percutaneous ethanol injection for benign cystic thyroid nodules: is aspiration of ethanol-mixed fluid advantageous?

Authors:  Dong Wook Kim; Myung Ho Rho; Hak Jin Kim; Jae Su Kwon; Young Sun Sung; Sang Wook Lee
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.

Authors:  G Costante; U Crocetti; E Schifino; O Ludovico; C Capula; M Nicotera; F Arturi; S Filetti
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 3.  Levothyroxine or minimally invasive therapies for benign thyroid nodules.

Authors:  Elizabeth Bandeira-Echtler; Karla Bergerhoff; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2014-06-18

Review 4.  Endocrine treatment of cancer.

Authors:  T Gulliford; R J Epstein
Journal:  J R Soc Med       Date:  1996-08       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.